- $81.95bn
- $80.75bn
- ¥780bn
- 100
- 10
- 62
- 59
Annual balance sheet for Advantest, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 149,164 | 116,582 | 85,537 | 106,702 | 262,544 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 57,028 | 82,155 | 102,152 | 88,855 | 113,031 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 279,095 | 304,945 | 374,695 | 420,261 | 599,753 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 53,281 | 64,037 | 81,358 | 97,990 | 96,940 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 422,641 | 494,696 | 600,224 | 671,229 | 854,210 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 89,811 | 150,882 | 174,689 | 126,277 | 309,424 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 142,272 | 200,075 | 231,530 | 240,051 | 347,671 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 280,369 | 294,621 | 368,694 | 431,178 | 506,539 |
| Total Liabilities & Shareholders' Equity | 422,641 | 494,696 | 600,224 | 671,229 | 854,210 |
| Total Common Shares Outstanding |